Individualising treatment for older people with diabetes

Lancet. 2013 Aug 3;382(9890):378-380. doi: 10.1016/S0140-6736(13)61055-7. Epub 2013 May 23.

Authors

John E Morley¹, Alan Sinclair²

Affiliations

¹ Division of Geriatric Medicine and Endocrinology, Saint Louis University School of Medicine, St Louis, MO 63104, USA. Electronic address: morley@slu.edu.
² Bedfordshire and Hertfordshire Postgraduate Medical School, University of Bedfordshire, Luton, Bedfordshire, UK; Institute of Diabetes for Older People, Luton, Bedfordshire, UK.

PMID: 23706758
DOI: 10.1016/S0140-6736(13)61055-7

No abstract available

Publication types

Comment

MeSH terms

Adamantane / administration & dosage
Adamantane / analogs & derivatives*
Diabetes Mellitus, Type 2 / drug therapy*
Female
Humans
Hypoglycemic Agents / administration & dosage*
Male
Nitriles / administration & dosage*
Pyrrolidines / administration & dosage*
Vildagliptin

Substances

Hypoglycemic Agents
Nitriles
Pyrrolidines
Vildagliptin
Adamantane